Movement Alert|Keysight Rises 3.11% in Regular Trading, Q3 Earnings and Guidance Beat Continue to Fuel Momentum

Market Focus
Sep 11

On September 11, Keysight rose 3.11% in regular trading, trading at approximately $335.78 per share, with turnover of $10.39 million. The stock continued to benefit from the sustained positive momentum following its fiscal Q3 earnings and Q4 guidance that both significantly exceeded Wall Street expectations.

Keysight reported fiscal Q3 revenue of $1.85 billion, up 36.5% year-over-year and well above the consensus estimate of $1.75 billion. Adjusted EPS surged approximately 79% to $3.07, crushing the $2.48 estimate. The company guided fiscal Q4 adjusted EPS of $3.34–$3.40 on revenue of $1.93–$1.95 billion, both materially above analyst forecasts of $2.68 and $1.83 billion, respectively. Orders exceeded $2 billion for the second consecutive quarter, driven by accelerating AI data center testing demand.

Multiple analysts raised their price targets following the results. Susquehanna lifted its target to $440, Truist to $400, while Morgan Stanley and JPMorgan both maintained overweight ratings with $400 targets. AI-related revenue is projected to rise from roughly 8% of total sales in fiscal 2025 to 20% in fiscal 2026. The current share price remains well below the average analyst target of $421.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10